In analysing the performance of the Online Pharmaceutical Sales industry over the past five years, it is necessary to view it in light of the significant changes occurring within the overall pharmaceuticals sector. Fundamental changes to the Pharmaceutical Benefits Scheme (PBS) has served to push prices downwards, as has the rise of generic products in view of the passing patent cliff. New business models adopted by pharmaceutical manufacturers, wholesalers and retailers alike have also served to stimulate change within the sector.
Companies in this industry primarily sell pharmaceutical products via the internet. This includes prescription and non-prescription medicines and associated personal care items. The industry excludes establishments that have a dual presence (both physical stores and online operations).
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.